PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24647425-10	2014	The expression of PI3K, P-Akt, COX-2, HIF-1alpha, VEGF-A and PTEN in tumor tissues treated with celecoxib was demonstrated by immunohistochemistry, and the MVD was decreased in a dose-dependent manner (P<0.05).	Celecoxib	96-105	hypoxia inducible factor 1, alpha subunit	Mus musculus	38-48	
24647425-12	2014	ELISA and western blotting data showed that the expression of PI3K, P-Akt, COX-2, HIF-1alpha and VEGF-A were reduced and PTEN was increased after treatment with celecoxib.	Celecoxib	161-170	hypoxia inducible factor 1, alpha subunit	Mus musculus	82-92	
24647425-13	2014	In conclusion, the impact of celecoxib-induced tumor growth delay of murine H22 hepatocarcinoma may correlate with the inhibition of angiogenesis by reducing PI3K, P-Akt, COX-2, HIF-1alpha and VEGF-A expression and increasing PTEN expression in tumor tissue.	Celecoxib	29-38	hypoxia inducible factor 1, alpha subunit	Mus musculus	178-188